Pfizer
Atul Goyal is a Senior Scientist at Pfizer, specializing in the purification process development for a polysaccharide vaccine targeting Streptococcus pneumoniae since September 2022. Prior to this role, Atul served as a Graduate Research Assistant at the University of Houston from August 2017 to August 2022, where involvement in various projects related to therapeutic monoclonal antibodies enhanced technical skills. Earlier experiences include summer internships at the University of Calgary and the University of Alberta, focusing on biomolecule expression and the advancement of NMR thermometry, respectively, as well as a Bachelor Thesis at the Indian Institute of Technology, Kharagpur, that explored composite structures with embedded sensors. Atul also completed an internship at the Defence Research and Development Organisation (DRDO), working with NMR technology to characterize organic matrix composites. Education includes a PhD in Chemical and Biomolecular Engineering from the University of Houston and a combined Bachelor's and Master's Degree in Chemical Engineering from the Indian Institute of Technology, Kharagpur.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.